# HR Combined With FOLFOX4 for HCC With PVTT

> **NCT02452853** · PHASE2 · UNKNOWN · sponsor: **Sun Yat-sen University** · enrollment: 51 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **PROCEDURE:** HR
- **DRUG:** FOLFOX4

## Key facts

- **NCT ID:** NCT02452853
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2016-05
- **Final completion:** 2018-05
- **Target enrollment:** 51 (ESTIMATED)
- **Last updated:** 2015-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02452853

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02452853, "HR Combined With FOLFOX4 for HCC With PVTT". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT02452853. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*